Linda Baddour, Chief Financial Officer at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 20,000 shares at $36.89 ($736K) on 2007-06-01, disclosed to the SEC on 2007-06-05.
Open-market sale of $736k PPDI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.73 | 820 | $30K | 4.1% |
| 2 | $36.74 | 380 | $14K | 1.9% |
| 3 | $36.75 | 1,160 | $43K | 5.8% |
| 4 | $36.76 | 2,500 | $92K | 12.5% |
| 5 | $36.77 | 700 | $26K | 3.5% |
| 6 | $36.78 | 1,300 |
| $48K |
| 6.5% |
| 7 | $36.83 | 1,400 | $52K | 7.0% |
| 8 | $36.84 | 2,390 | $88K | 12.0% |
| 9 | $36.85 | 3,550 | $131K | 17.8% |
| 10 | $36.86 | 2,300 | $85K | 11.5% |
| 11 | $36.87 | 2,100 | $77K | 10.5% |
| 12 | $36.88 | 300 | $11K | 1.5% |
| 13 | $36.89 | 423 | $16K | 2.1% |
| 14 | $36.90 | 577 | $21K | 2.9% |
| 15 | $36.91 | 100 | $4K | 0.5% |
| Total | $36.82 avg | 20,000 | $736K | 100% |
| Filing → |
| WAT | SELL | 2021-05-14 | $787K | — | Filing → |
| PRAH | SELL | 2018-01-18 | $12.1M | — | Filing → |
| PRAH | SELL | 2017-08-16 | $15.0M | — | Filing → |